Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Health
|
Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
|
Policies or Program
|
Health
|
Food and Drug Regulations with respect to Data Protection under. C.08.004
|
Regulation
|
Health
|
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
|
Policies or Program
|
Health
|
Health Canada Health Products & Food Regulatory Modernization
|
Policies or Program
|
Economic Development, Industry, Intellectual Property, Research and Development, Science and Technology
|
Innovation Agenda led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences sector
|
Policies or Program
|
Health
|
Medical Devices Regulations under the Food and Drugs Act, specifically with respect to the approval, regulation and life cycle management of medical devices
|
Regulation
|
Health, Intellectual Property
|
Patent Act as it relates to the regulation of intellectual property for therapeutic products
|
Policies or Program
|
Health, Intellectual Property
|
Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations
|
Regulation
|
Health, Intellectual Property
|
Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
|
Policies or Program
|
Health
|
Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
|
Policies or Program
|
Health
|
Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
|
Policies or Program
|
Health, International Trade
|
Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
|
Policies or Program
|
Address:
200 Whitehall Drive
Markham, ON L3R 0T5
Canada
Telephone number:
905-946-8999
Lesia Babiak, Chair, Government Affairs Council, Johnson & Johnson Family of Companies
Johnson & Johnson Family of Companies In Canada is not a coalition.
Johnson & Johnson Family of Companies In Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Stephen Sampson | Public offices held
Firm: Global Public Affairs